Analgesia – AlgiScan

Intensive care

The AlgiScan uses pupillometry technology to objectively measure the patient’s level of analgesia.

This technic is well published and documented. It offers robust and relevant results for the evaluation of the sensibility level to nociception and the prediction of haemodynamic reactions to nociceptive stimuli. The fast and non invasive measurements bring unequalled precision while safe for the eye.

The integrated lighting system offers the possibility to do the routine check of the pupil size and reactivity with reliable measurements.

With its small size it is possible to position the AlgiScan on all types of morphology and to easily access the pupil for measurements in PACU and ICU. The AlgiScan is a portable and intuitive device for the assessment of patient analgesia in all situations.

Its reusable and autoclavable eyecup eliminates any extra cost in use. Its design and the materials used provide ergonomics and absolute comfort for the patient while eliminating the influence of ambient lights on measurement results.

The STA-W1 charging station makes it easy to recharge the AlgiScan at any time.

Technical Data

CLINICAL

  • Measurements of patients’ analgesia level (PPI score, Tetanus,…)
  • Pupil Reflex Dilation (PRD)
  • Pupil size
  • Photomotor reflex

ERGONOMICS

  • Absolute measurements without calibration
  • Wireless charging station
  • Barcode scanning for patient identification
  • Reusable or disposable eyecup

STANDARDS AND SAFETY

  • EN60601-1 (Medical Electrical Equipment)
  • EN60601-1-2 (EMC)
  • IEC 62471 (Infrared light)
  • IIA CE Class (CE 0549)
  • Latex Free

SPECIFICITY

  • Stimulations : infra-nociceptive (PPI), Tetanos
  • 320 Lux flash of light
  • 0,1 mm precision
  • Data transfer
  • Opaque eyecup to impede ambient light

Eco-friendly company

We are an
eco-friendly company

Open ended choice of
disposable or reusable material

Cost
control

Short production
cycle

PUBLICATIONS

  • "Pupillary reflex dilation in response to incremental nociceptive stimuli in patients receiving intravenous ketamine." Sabourdin N, Giral T, Wolk R, Louvet N, Constant I.

    Pupillometry is a non-invasive monitoring technique, which allows dynamic pupillary diameter measurement by an infrared camera. Pupillary diameter increases in response to nociceptive stimuli. In patients anesthetized with propofol or volatile agents, the magnitude of this pupillary dilation is related to the intensity of the stimulus. Pupillary response to nociceptive stimuli has never been studied under ketamine anesthesia. Our objective was to describe pupillary reflex dilation after calibrated tetanic stimulations in patients receiving intravenous ketamine. After written consent, 24 patients of our pediatric burn care unit were included.

    Click here to read the abstract

    J Clin Monit Comput. 2017 Oct 17. doi: 10.1007/s10877-017-0072-5.
  • "Pupillary reflex measurement predicts insufficient analgesia before endotracheal suctioning in critically ill patients" Paulus J, Roquilly A, Beloeil H, Théraud J, Asehnoune K, Lejus C.

    This study aimed to evaluate the pupillary dilatation reflex (PDR) during a tetanic stimulation to predict insufficient analgesia before nociceptive stimulation in the intensive care unit (ICU).

    Click here to read the abstract

    Crit Care. 2013 Jul 24;17(4):R161. doi: 10.1186/cc12840.

They trust us

IDMED WorldWide

Nos pupillomètres (AlgiScan, MAPstation, NeuroLight) et notre curamètre (ToFscan) sont disponibles dans le monde entier.

Nos collaborateurs et distributeurs sont à votre écoute pour répondre à vos besoins et aux besoins de vos patients.

legende_carre-Distributeurs_IDMED_implantesDistributeurs implantés
*Distributors located
legende_carre-Distributeurs_IDMED_en_cours_d_implantationDistributeurs en cours d’implantation
*Distributors being implemented

IDMED

Hôtel Technoptic
2 rue Marc Donadille
13013 Marseille – FRANCE

+33(0)4 91 11 87 84

Contact us:

Hospital/Company
City
Name (*required)
Phone
Email (*required)
Message *
   By submitting this form, I agree that the information entered will be used, exploited and processed to allow me to recontact myself in the context of the commercial relationship that arises from my inquiry.